At Siemens Healthineers (SHS), our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. An estimated five million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With about ~50,000 dedicated colleagues in over 70 countries, we will continue to innovate and shape the future of healthcare. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and profit of €2.3 billion – representing a profit margin of 17.2 %. We empower innovative therapy concepts and minimally invasive procedures with our angiography systems, mobile C-arms, and hybrid ORs for image-guided therapy. As an integral part of the Healthineers innovation force, the Technology Center (TC) is catalyzing mid to long-term innovation and future growth in new and established SHS businesses, safeguarding proper IP management. Since 4 years the TC is pursuing extensive R&D activities in the field of perovskites used as direct X-Ray converters. Within PEROXIS, SHS will design, fabricate and characterize thick (>500µm) perovskite layers as direct X-Ray converters exploiting the soft-sintering route (top-down approach) for the deposition of the frontplane onto the backplane. Main task will be the upscaling of the deposition process on large areas (20×20 cm²), the improvement of devices stability and the adhesion enhancement on the backplane. SHS will be the WP lead of WP2 “Powder sintering approach (top-down perovskite integration)”. In WP2 SHS will continue the excellent collaboration with TNO, built-up during the H2020 – DiCoMo Project, by leveraging synergies from both parties.
May 10, 2022
Excellent stability of perovskite X-ray detectors
We have illustrated that the perovskite MAPbI3 detector shows outstanding X-ray imaging performance even after 1.5 years of storage in ambient condition. Further improvements of the surface passivation of the pixelated X-ray imaging detector are still needed. This research highlights the great potential of perovskite technology to take X-ray imaging to the next step towards a new era in medical imaging.